Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1,1890
Trial Sponsor
Clinical Trial Start Date
March 11, 2015
0Primary Completion Date
2016
0Study Completion Date
2017
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
NKTR-181 BID tablets0
Placebo to match NKTR-181 BID tablets0
Interventional Trial Phase
Phase 30
Official Name
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain0
Last Updated
September 16, 2020
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Care Provider0
Outcomes Assessor0
Participant0
Investigator0
Study summary
The purpose of this study is to determine whether a new opioid molecule, NKTR-181, is effective for the relief of moderate to severe chronic low back pain as compared to a placebo.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
